Request for Input: 2022 Revisions to USP
The Advisory Pharmacy Compounding Education Committee (APCEC) is working on recommendations
for adopting the 2022 revisions to USP <797>, USP <795>, and USP <800> into Utah State Regulation.
The Committee is requesting input about how to best adopt these new recommendations.
For more information, please refer to this document: USP Update Letter
Elimination of DATA-Waiver Program
A DATA-Waiver registration is no longer required to treat patients with buprenorphine for opioid use disorder. For more information about the elimination of the DATA-Waiver requirement, please refer to this document: DOPL Notice of Elimination of DATA-Waiver Program
DOPL Temporarily Suspends Enforcement of e-Prescribing Requirement for Controlled Substances
- See Pharmacy E-Prescribing Law Delay Notice effective 01/01/2022
Electronic Prescriptions for Controlled Substances
Beginning January 1, 2022, Utah Code Annotated 58-37-22 requires that most* prescriptions issued for a controlled substance be transmitted electronically as an electronic prescription; however, you may apply for a limited extension by submitting the form linked below.
*FOR INFORMATION ON EXEMPTIONS, PLEASE SEE UTAH CODE ANNOTATED 58-37-22.
While a prescriber is permitted to use any vendor, the Division* is aware of the vendors identified on the list below.
*THE DIVISION DOES NOT ENDORSE ANY PARTICULAR VENDOR, AND THE INFORMATION ON THIS RESOURCE SHEET MAY CHANGE AT ANY TIME.